Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-12-07
2008-11-11
Seaman, D. Margaret (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S314000, C514S312000, C514S343000, C514S423000, C514S422000, C546S159000, C546S160000, C546S279100, C546S153000, C549S537000
Reexamination Certificate
active
07449479
ABSTRACT:
Hepatitis C virus inhibitors are disclosed having the general formula:wherein R1, R2, R3, R′, B, Y and X are described in the description.Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
REFERENCES:
patent: 6995174 (2006-02-01), Wang et al.
patent: 7135462 (2006-11-01), Scola et al.
patent: 2005/0153877 (2005-07-01), Miao et al.
patent: 2006/0199773 (2006-09-01), Sausker et al.
patent: WO 98/17679 (1998-04-01), None
patent: WO 99/07733 (1999-02-01), None
patent: WO 99/07734 (1999-02-01), None
patent: WO 00/09543 (2000-02-01), None
patent: WO 00/09558 (2000-02-01), None
patent: WO 2004/103996 (2000-02-01), None
patent: WO 00/59929 (2000-10-01), None
patent: WO 02/060926 (2002-08-01), None
patent: WO 03/053349 (2003-07-01), None
patent: WO 03/064416 (2003-08-01), None
patent: WO 03/064455 (2003-08-01), None
patent: WO 03/064456 (2003-08-01), None
patent: WO 03/066103 (2003-08-01), None
patent: WO 03/099274 (2003-12-01), None
patent: WO 03/099316 (2003-12-01), None
patent: WO 2004/009121 (2004-01-01), None
patent: WO 2004/032827 (2004-04-01), None
patent: WO 2004/037855 (2004-05-01), None
patent: WO 2004/043339 (2004-05-01), None
patent: WO 2004/072243 (2004-08-01), None
patent: WO 2004/093798 (2004-11-01), None
patent: WO 2004/093915 (2004-11-01), None
patent: WO 2004/094452 (2004-11-01), None
patent: WO 2004/101602 (2004-11-01), None
patent: WO 2004/101605 (2004-11-01), None
patent: WO 2004/113365 (2004-12-01), None
patent: WO 2005/010029 (2005-02-01), None
patent: WO 2005/028501 (2005-03-01), None
patent: WO 2005/037214 (2005-04-01), None
patent: WO 2005/037860 (2005-04-01), None
patent: WO 2005/046712 (2005-05-01), None
patent: WO 2005/051410 (2005-06-01), None
patent: WO 2005/051980 (2005-06-01), None
patent: WO 2005/054430 (2005-06-01), None
patent: WO 2005/070955 (2005-08-01), None
patent: WO 2005/073216 (2005-08-01), None
patent: WO 2005/095403 (2005-10-01), None
patent: WO 2005/116054 (2005-12-01), None
patent: WO 2006/000085 (2006-01-01), None
patent: WO 2006/007700 (2006-01-01), None
patent: WO 2006/007708 (2006-01-01), None
patent: WO 2006/016930 (2006-02-01), None
patent: WO 2006/020276 (2006-02-01), None
patent: WO 2006/026352 (2006-03-01), None
patent: WO 2006/033878 (2006-03-01), None
patent: WO 2006/043145 (2006-04-01), None
patent: WO 2006/086381 (2006-08-01), None
patent: WO 2006/096652 (2006-09-01), None
patent: WO 2006/119061 (2006-11-01), None
patent: WO 2006/122188 (2006-11-01), None
U.S. Appl. No. 11/591,253, filed Nov. 1, 2006, D'Andrea et al.
U.S. Appl. No. 11/415,722, May 2, 2006, Wenying Li.
U.S. Appl. No. 11/481,536, Jul. 6, 2006, Hewawasam et al.
Lauer, G.M. and Walker, B.D., “Hepatitis C Virus Infection”,N. Engl. J. Med., 2001, 345, 41-52.
Poupart, M.-A., Cameron, D.R., Chabot, C., Ghiro, E., Goudreau, N., Boulet, S., Poirier, M., and Tsantrizos, Y.S., “Solid-Phase Synthesis of Peptidomimetic Inhibitors for the Hepatitis C Virus NS3 Protease”,J. Org. Chem., 2001, 66, 4743-4751.
Campbell Jeffrey Allen
Chen Yan
Good Andrew Charles
Hewawasam Piyasena
Scola Paul Michael
Bristol--Myers Squibb Company
Mingo Pamela A.
Seaman D. Margaret
Volles Warren K.
LandOfFree
Hepatitis C virus inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hepatitis C virus inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatitis C virus inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4036078